2012 ACR/EULAR PMR 分类
用途适用： age≥50 with bilateral shoulder aching and raised CRP/ESR when PMR classification is considered.
分层Meets threshold → classifies as PMR; always screen clinically for GCA.
局限不适用： without entry criteria, or when late-onset RA better explains th… · 易错点： missing GCA red flags (vision, jaw claudication, new headache). · Classification ≠ automatic steroid protocol.
出处中华医学会风湿病学分会 PMR 相关共识 on zh when available
本班次下一步
评完分数后：进场景连算、看相邻评分、打开对应路径。本地参考，不写入 HIS。
方法学 · 公式代入、指南要点与完整说明
适用场景
适用： age≥50 with bilateral shoulder aching and raised CRP/ESR when PMR classification is considered.
需要填写的项目
- Age ≥50 + bilateral shoulder aching + abnormal CRP and/or ESR · 选项
- Morning stiffness > 45 minutes · 选项
- Hip pain or limited hip ROM · 选项
- RF and/or ACPA negative · 选项
- Absence of other joint involvement · 选项
- Ultrasound available / used in scoring? · 选项
- US: both shoulders abnormal · 选项
- US: ≥1 shoulder AND ≥1 hip abnormal · 选项
计算方法与公式
Morning stiffness>45 min (2) + hip pain/ROM (1) + RF/ACPA neg (2) + no other joints (1) ± US (both shoulders 1; shoulder+hip 1).
Confirm entry features first; add US points only if using the US pathway.
公式代入演示
下列数值取自本工具各输入项的示例值，用本页公式在服务端实际算出，供快速核对计算过程。仅演示代入方法，不构成临床建议，也不代表任何真实病例。
| Age ≥50 + bilateral shoulder aching + abnormal CRP and/or ESR | 否 |
|---|---|
| Morning stiffness > 45 minutes | 否 (0) |
| Hip pain or limited hip ROM | 否 (0) |
| RF and/or ACPA negative | No (positive) (0) |
| Absence of other joint involvement | No (other joints involved) (0) |
| Ultrasound available / used in scoring? | No US pathway (threshold ≥4) |
| US: both shoulders abnormal | No / N/A (0) |
| US: ≥1 shoulder AND ≥1 hip abnormal | No / N/A (0) |
→ACR/EULAR PMRNot applicable
- Entry：Needs age≥50, bilateral shoulder aching, abnormal CRP/ESR.
| Age ≥50 + bilateral shoulder aching + abnormal CRP and/or ESR | Yes (required) |
|---|---|
| Morning stiffness > 45 minutes | 是 (2) |
| Hip pain or limited hip ROM | 是 (1) |
| RF and/or ACPA negative | Yes — negative (2) |
| Absence of other joint involvement | Yes — absent (1) |
| Ultrasound available / used in scoring? | US pathway (threshold ≥5) |
| US: both shoulders abnormal | 是 (1) |
| US: ≥1 shoulder AND ≥1 hip abnormal | 是 (1) |
→PMR score8
- Threshold：≥ 5 (with US)
- Classification：Classifies as PMR
结果判读与分层
Meets threshold → classifies as PMR; always screen clinically for GCA.
指南要点（原创整理）
- Entry triad required.
- Threshold 4 vs 5 with US.
- 下一步： GCA assessment; CN rheumatology PMR guidance on zh.
以上为依据相应指南的关键推荐、由本站用自己的语言归纳整理（非指南原文）；完整内容请见下方官方来源。
注意事项与局限
- 不适用： without entry criteria, or when late-onset RA better explains the picture.
- 易错点： missing GCA red flags (vision, jaw claudication, new headache).
- Classification ≠ automatic steroid protocol.
核对与出处 · 可验证治理
参考指南与出处
- [指南 / 主要来源]中华医学会风湿病学分会 PMR 相关共识 on zh when available
- Dasgupta B, et al. Arthritis Rheum / Ann Rheum Dis 2012 · 来源 ↗
指南全文版权归相应学会/期刊所有；本工具仅实现其决策算法并注明出处，全文请经上方官方来源获取。
依据文献年份见参考 · 数据集整理日 2026-10-08
常见问题
常见问题
- 2012 ACR/EULAR PMR 分类的计算是否上传患者数据？在哪里计算？
- 计算在浏览器本地完成，输入与结果不上传服务器；结果仅供执业医师参考，须结合病史、检查与本机构方案判断，不构成诊断或处方依据。
- 2012 ACR/EULAR PMR 分类怎么代入计算？能举个例子吗？
- 代入: Age ≥50 + bilateral shoulder aching + abnormal CRP and/or ESR 否、Morning stiffness > 45 minutes 否 (0)、Hip pain or limited hip ROM 否 (0)、RF and/or ACPA negative No (positive) (0)、Absence of other joint involvement No (other joints involved) (0)、Ultrasound available / used in scoring? No US pathway (threshold ≥4)、US: both shoulders abnormal No / N/A (0)、US: ≥1 shoulder AND ≥1 hip abnormal No / N/A (0) → 结果: ACR/EULAR PMR Not applicable（Entry: Needs age≥50, bilateral shoulder aching, abnormal CRP/ESR.） 代入: Age ≥50 + bilateral shoulder aching + abnormal CRP and/or ESR Yes (required)、Morning stiffness > 45 minutes 是 (2)、Hip pain or limited hip ROM 是 (1)、RF and/or ACPA negative Yes — negative (2)、Absence of other joint involvement Yes — absent (1)、Ultrasound available / used in scoring? US pathway (threshold ≥5)、US: both shoulders abnormal 是 (1)、US: ≥1 shoulder AND ≥1 hip abnormal 是 (1) → 结果: PMR score 8（Threshold: ≥ 5 (with US)、Classification: Classifies as PMR）
核对流程与方法学
核对与依据
本工具的公式与计算方法已在本页明示、公开可逐一核查。其公式、系数与阈值依据上方「参考指南与出处」列出的权威来源核对。想了解本站对全部临床工具的核对流程与出处覆盖情况，见 临床工具核对表与方法学 →